Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy
J. Clin. Invest. Linqi Zhang, et al. 106:839 doi:10.1172/JCI10565 [
Go to this article.]
Figure 3Length polymorphism of the rebounding plasma virus in comparison with those isolated from the latent reservoir during therapy and those in the plasma before therapy. Multiple samples collected after cessation of HAART are separated into three time groups: 14–42 days, 43–140 days, and 141–280 days. The V1–V2 region is shown in red; the V4–V5 region is shown in blue. The size of each peak is indicated by the scale at the top of each panel.
